Skip to main content

New Products: Jan 15, 2009


AnaSpec last week introduced its newest ClearPoint heavy or isotope-labeled peptides and amino acids.

The peptides can be used for the quantitative analysis of beta-amyloid peptides in biological fluids using mass spectrometry. Beta-amyloid peptides have been used as biomarkers for Alzheimer's disease. ELISAs have been used to quantify these peptides, but technical challenges such as the tendency of beta-amyloids to self-aggregate, undergo post-translational modification, or bind to other proteins can lead to inaccurate results, AnaSpec said in a statement.

"The inclusion of internal heavy isotope labeled peptide standards makes mass spectrometry an absolute quantitation method for the peptide of interest," the company said.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.